Showing articles whose micro-themes are very close to:
#HTA process
- No closely related articles found yet.
- NCPE Ireland HTA for Opdualag (nivolumab+relatlimab) for advanced melanoma: status update (ncpe.ie) | 68d ago
- NCPE Releases Full HTA Submission Template Version 3.1 for Pharmacoeconomic Assessments in Ireland (ncpe.ie) | 678d ago
- NCPE Recommends Against Reimbursement of Belzutifan (Welireg) for von Hippel-Lindau Disease in Ireland (ncpe.ie) | 65d ago
- NCPE Rapid Review Template Version 2.2 for Drug Reimbursement Submissions in Ireland (ncpe.ie) | 932d ago
- HIQA finds insufficient evidence that shingles vaccine prevents dementia (imt.ie) | 67d ago
- HIQA Publishes Health Technology Assessment on Herpes Zoster Vaccine (oireachtas.ie) | 125d ago
- HIQA Commences Health Technology Assessment on COVID-19 Vaccination in Ireland (hiqa.ie) | 85d ago
- Government Commits to Six-Month Deadline for Drug Reimbursement Decisions in Ireland (imt.ie) | 64d ago
- HIQA Annual Report 2023 details 2,189 inspections and preparations for new patient safety functions (hiqa.ie) | 795d ago
- HIQA Public Consultation on HTA of COVID-19 Vaccination in Ireland (hiqa.ie) | 33d ago
Showing page 1 of 1
(10 total results)
← Prev
Next →